SE420566B - Diagnostiseringsmedel for intravaskuler administrering - Google Patents

Diagnostiseringsmedel for intravaskuler administrering

Info

Publication number
SE420566B
SE420566B SE7407461A SE7407461A SE420566B SE 420566 B SE420566 B SE 420566B SE 7407461 A SE7407461 A SE 7407461A SE 7407461 A SE7407461 A SE 7407461A SE 420566 B SE420566 B SE 420566B
Authority
SE
Sweden
Prior art keywords
june
blood plasma
water
intravascularly
intravascular administration
Prior art date
Application number
SE7407461A
Other languages
English (en)
Swedish (sv)
Other versions
SE7407461L (sv
Inventor
U S E Rothman
B J Lindberg
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE7407461A priority Critical patent/SE420566B/xx
Priority to AU81646/75A priority patent/AU8164675A/en
Priority to DE19752524278 priority patent/DE2524278A1/de
Priority to GB24287/75A priority patent/GB1518813A/en
Priority to CA228,779A priority patent/CA1039274A/en
Priority to FR7517632A priority patent/FR2273516A1/fr
Priority to NL7506743A priority patent/NL7506743A/xx
Priority to JP50067731A priority patent/JPS517113A/ja
Publication of SE7407461L publication Critical patent/SE7407461L/xx
Publication of SE420566B publication Critical patent/SE420566B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1217—Dispersions, suspensions, colloids, emulsions, e.g. perfluorinated emulsion, sols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1241—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins
    • A61K51/1244—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules particles, powders, lyophilizates, adsorbates, e.g. polymers or resins for adsorption or ion-exchange resins microparticles or nanoparticles, e.g. polymeric nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B31/00—Preparation of derivatives of starch
    • C08B31/003—Crosslinking of starch
    • C08B31/006—Crosslinking of derivatives of starch
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2123/00—Preparations for testing in vivo

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Optics & Photonics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Endocrinology (AREA)
  • Materials Engineering (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pathology (AREA)
  • Rheumatology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Nanotechnology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE7407461A 1974-06-06 1974-06-06 Diagnostiseringsmedel for intravaskuler administrering SE420566B (sv)

Priority Applications (8)

Application Number Priority Date Filing Date Title
SE7407461A SE420566B (sv) 1974-06-06 1974-06-06 Diagnostiseringsmedel for intravaskuler administrering
AU81646/75A AU8164675A (en) 1974-06-06 1975-05-29 A diagnostic agent
DE19752524278 DE2524278A1 (de) 1974-06-06 1975-05-31 Diagnostisches mittel, hilfsmittel zu dessen herstellung sowie diagnoseverfahren
GB24287/75A GB1518813A (en) 1974-06-06 1975-06-05 Diagnostic agent
CA228,779A CA1039274A (en) 1974-06-06 1975-06-05 Diagnostic agent
FR7517632A FR2273516A1 (fr) 1974-06-06 1975-06-05 Agent de diagnostic pour l'administration intravasculaire
NL7506743A NL7506743A (nl) 1974-06-06 1975-06-06 Diagnosticum.
JP50067731A JPS517113A (cg-RX-API-DMAC7.html) 1974-06-06 1975-06-06

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE7407461A SE420566B (sv) 1974-06-06 1974-06-06 Diagnostiseringsmedel for intravaskuler administrering

Publications (2)

Publication Number Publication Date
SE7407461L SE7407461L (sv) 1975-12-08
SE420566B true SE420566B (sv) 1981-10-19

Family

ID=20321348

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7407461A SE420566B (sv) 1974-06-06 1974-06-06 Diagnostiseringsmedel for intravaskuler administrering

Country Status (8)

Country Link
JP (1) JPS517113A (cg-RX-API-DMAC7.html)
AU (1) AU8164675A (cg-RX-API-DMAC7.html)
CA (1) CA1039274A (cg-RX-API-DMAC7.html)
DE (1) DE2524278A1 (cg-RX-API-DMAC7.html)
FR (1) FR2273516A1 (cg-RX-API-DMAC7.html)
GB (1) GB1518813A (cg-RX-API-DMAC7.html)
NL (1) NL7506743A (cg-RX-API-DMAC7.html)
SE (1) SE420566B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002772A1 (en) * 1983-12-21 1985-07-04 Schroeder Ulf Diagnostic and contrast agent

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0093757A1 (en) * 1981-11-12 1983-11-16 Ulf SCHRÖDER Intravascularly administrable, magnetically responsive nanosphere or nanoparticle, a process for the production thereof, and the use thereof
FR2548902B1 (fr) * 1983-07-13 1986-04-11 Guerbet Sa Gel pour embolisation therapeutique

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985002772A1 (en) * 1983-12-21 1985-07-04 Schroeder Ulf Diagnostic and contrast agent

Also Published As

Publication number Publication date
NL7506743A (nl) 1975-12-09
AU8164675A (en) 1976-12-02
GB1518813A (en) 1978-07-26
FR2273516B1 (cg-RX-API-DMAC7.html) 1979-01-05
FR2273516A1 (fr) 1976-01-02
SE7407461L (sv) 1975-12-08
CA1039274A (en) 1978-09-26
JPS517113A (cg-RX-API-DMAC7.html) 1976-01-21
DE2524278A1 (de) 1975-12-18

Similar Documents

Publication Publication Date Title
EP0787017B2 (en) Diagnostic preparation for detection of helicobacter pylori
CA1165686A (en) Radioactive diagnostic agent and non-radioactive carrier therefor
Caldwell et al. Interruption of the enterohepatic circulation of digitoxin by cholestyramine: II. Effect on metabolic disposition of tritium-labeled digitoxin and cardiac systolic intervals in man
US5068226A (en) Pharmaceutical preparations containing cyclodextrins and their use in iontophoretic therapies
US4071613A (en) Stabilized alcohol solution of reducing salt formulations for use in preparing radioisotope labeled scanning agents: liver scanning technetium-99m colloid and method of preparation
Whitby Enzymic formation of a new riboflavin derivative
NL7506743A (nl) Diagnosticum.
Schilsky et al. Biliary copper excretion capacity in intact animals: correlation between ATP7B function, hepatic mass, and biliary copper excretion
EP0063946A1 (en) Diagnosis of kidney function
DE69001000T2 (de) Radioaktives diagnosemittel.
Esquerre et al. Kinetics of technetium-labeled heparin in thromboembolism: Preliminary report
Ainsworth An ultrastructural method for the use of polyvinylpyrrolidone and dextrans as electron opaque tracers.
Wingårdh et al. Evaluation in vitro and in vivo of two labelling techniques of different 99mTc-dextrans for lymphoscintigraphy
JPS5842846B2 (ja) 肝臓および骨髄走査用テクネチウム−９９ｍ標識放射線診断剤とその製造法
Balaban et al. Effect of the radiolabel mediator tropolone on lymphocyte structure and function
CN111377968A (zh) 一类含芳基硼酸的99mTc（Ⅲ）配合物及其药盒配方和应用
Hudson et al. Tumour uptake of thallium-201 chloride
Turan et al. Evaluation of 99mTc-citrate, 67Gacitrate and 99mTc (V) dimercaptosuccinic acid for the scintigraphic visualization of acute appendicitis
Feinendegen et al. On behalf of I-123 fatty acids for myocardial metabolic imaging
JPS63170400A (ja) 放射性医薬品とその調製用高分子化合物
GB2055044A (en) Glucuronidase activity and/or phdependent pharmaceuticals and their methods of production and use for selective treatment of diseases
Duchon Tyrosine metabolism in melanoma
JPS60126231A (ja) 放射性診断剤
Chatterjee Debnath et al. Technetium-99m cysteine; a novel radiopharmaceutical for detection of experimental myocardial infarction in rats
King et al. Laboratory methods for screening possible inhibitors of dental caries